Advertisement
Research Article

Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1

  • Iliyana Mikell,

    Affiliations: Seattle BioMed, Seattle, Washington, United States of America, Department of Global Health, University of Washington, Seattle, Washington, United States of America

    X
  • D. Noah Sather,

    Affiliation: Seattle BioMed, Seattle, Washington, United States of America

    X
  • Spyros A. Kalams,

    Affiliation: Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

    X
  • Marcus Altfeld,

    Affiliation: Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, United States of America

    X
  • Galit Alter,

    Affiliation: Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, United States of America

    X
  • Leonidas Stamatatos mail

    leo.stamatatos@seattlebiomed.org

    Affiliations: Seattle BioMed, Seattle, Washington, United States of America, Department of Global Health, University of Washington, Seattle, Washington, United States of America

    X
  • Published: January 13, 2011
  • DOI: 10.1371/journal.ppat.1001251

Reader Comments (0)

Post a new comment on this article